# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Multiple sclerosis

MS
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 121-130 of 488 results.
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
Status: Recruiting
Last Changed: Jan 03, 2020
First Received: Dec 15, 2016
Disease(s): Multiple Sclerosis
Locations: University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Exergaming in Persons With Multiple Sclerosis With Restless Legs Syndrome
Status: Recruiting
Last Changed: Oct 08, 2019
First Received: Mar 18, 2019
Disease(s): Multiple Sclerosis
Intervention(s): Exergaming
Locations: MS Outpatient Clinic, Dokuz Eylul University Hospital, Izmir, Turkey
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: May 06, 2020
Disease(s): Multiple Sclerosis, Relapsing
Intervention(s): Ocrelizumab
Locations: HonorHealth Neurology, Scottsdale, Arizona, United States
USC Keck School Of Medicine, Los Angeles, California, United States
Georgetown University Medical Center, Washington, District of Columbia, United States
Baptist Neurology - Beaches, Jacksonville Beach, Florida, United States
University of Miami Miller School of Medicine, Miami, Florida, United States
... and 28 other locations.
Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis
Status: Recruiting
Last Changed: Oct 17, 2019
First Received: Oct 17, 2019
Disease(s): Multiple Sclerosis, Pharmacokinetics
Intervention(s): Teriflunomide 14 MG
Locations: MS Centre, Gothenburg, Vastra Gotaland, Sweden
Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region
Status: Not yet recruiting
Last Changed: Jul 22, 2020
First Received: Jul 13, 2020
Disease(s): Relapsing Remitting Multiple Sclerosis
Intervention(s): Dimethyl Fumarate (DMF)
A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children With Multiple Sclerosis
Status: Recruiting
Last Changed: Mar 10, 2020
First Received: Oct 10, 2019
Disease(s): Multiple Sclerosis (MS)
Intervention(s): Metformin, Placebo
Locations: The Hospital for Sick Children, Toronto, Ontario, Canada
Self-administered Hyperinsufflation Chest on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit
Status: Not yet recruiting
Last Changed: Sep 30, 2020
First Received: Sep 24, 2020
Disease(s): Multiple Sclerosis
Intervention(s): Standardized respiratory management program, CoughAssist
Improving Mobility and Reducing Fatigue in People With Multiple Sclerosis by Electrical Stimulation Therapy
Status: Not yet recruiting
Last Changed: Aug 13, 2019
First Received: Sep 25, 2018
Disease(s): Multiple Sclerosis
Intervention(s): Transcutaneous electrical nerve stimulation
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
Status: Recruiting
Last Changed: Jun 17, 2020
First Received: Aug 08, 2018
Disease(s): Multiple Sclerosis
Intervention(s): Telephone-based Cognitive Behavioral Therapy, Modafinil
Locations: The University of Michigan, Ann Arbor, Michigan, United States
The University of Washington, Seattle, Washington, United States
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis
Status: Recruiting
Last Changed: Oct 08, 2020
First Received: Jun 03, 2019
Disease(s): Multiple Sclerosis (MS)
Intervention(s): Ocrelizumab, Ocrelizumab, rHuPH20
Locations: University of Colorado; Anschutz Medical Campus Department of Neurology, Aurora, Colorado, United States
Advanced Neurosciences Res LLC, Fort Collins, Colorado, United States
Georgetown University Medical Center, Washington, District of Columbia, United States
Riverside Clinical Research, Edgewater, Florida, United States
University of South Florida School of Medicine Morsani Center for Advanced Health Care, Tampa, Florida, United States
... and 24 other locations.